These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8414219)

  • 21. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
    Kato T; Karai N; Katsuyama M; Nakamura M; Katsube J
    Biochem Pharmacol; 1987 Sep; 36(18):3051-7. PubMed ID: 3115271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
    Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
    J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulatory effect of 4-alkylcatechols and their diacetylated derivatives on the synthesis of nerve growth factor.
    Furukawa Y; Fukazawa N; Miyama Y; Hayashi K; Furukawa S
    Biochem Pharmacol; 1990 Nov; 40(10):2337-42. PubMed ID: 2244935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alkylcatechols regulate NGF gene expression in astroglial cells via both protein kinase C- and cAMP-independent mechanisms.
    Furukawa Y; Furukawa S; Omae F; Awatsuji H; Hayashi K
    J Neurosci Res; 1993 Aug; 35(5):522-9. PubMed ID: 8397306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W; Naoi M; Narabayashi H
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of aluminum(III) on catechol-stimulated nerve growth factor biosynthesis by cultured mouse brain astroglial cells.
    Kobayashi D; Murase K; Odani A; Hayashi K; Yamauchi O
    Biochem Mol Biol Int; 1996 Apr; 38(4):675-84. PubMed ID: 8728096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
    Karai N; Kato T; Katsuyama M; Nakamura M; Katsube J
    Life Sci; 1987 Jun; 40(23):2261-8. PubMed ID: 3108598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A; Jackson-Lewis V; Fahn S
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperative regulation of nerve growth factor synthesis and secretion in fibroblasts and astrocytes by fibroblast growth factor and other cytokines.
    Yoshida K; Gage FH
    Brain Res; 1992 Jan; 569(1):14-25. PubMed ID: 1377078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S; Hayashi A; Kondo T; Narabayashi H
    Neurology; 1984 Nov; 34(11):1446-50. PubMed ID: 6436731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial attenuating effect of L-threo-3,4-dihydroxyphenylserine on postural hypotension in anesthetized rats.
    Satoh S; Oyabe A; Tanno M; Suzuki-Kusaba M
    Arzneimittelforschung; 1989 Sep; 39(9):1123-9. PubMed ID: 2511849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of L-threo-dihydroxyphenylserine on spinal reflexes and decerebrate rigidity in rats.
    Ono H; Tanabe M; Nakamura T; Nagano N; Fukuda H
    Gen Pharmacol; 1988; 19(3):369-72. PubMed ID: 3138156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
    Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
    J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
    Goldstein DS; Holmes C; Kaufmann H; Freeman R
    Clin Auton Res; 2004 Dec; 14(6):363-8. PubMed ID: 15666063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson's disease.
    Ogawa N; Yamamoto M; Takayama H
    J Med; 1985; 16(5-6):525-34. PubMed ID: 3938472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The reactivity of o-quinones which do not isomerize to quinone methides correlates with alkylcatechol-induced toxicity in human melanoma cells.
    Bolton JL; Pisha E; Shen L; Krol ES; Iverson SL; Huang Z; van Breemen RB; Pezzuto JM
    Chem Biol Interact; 1997 Sep; 106(2):133-48. PubMed ID: 9366899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
    Yamamoto M; Ogawa N; Ujike H
    J Neurol Sci; 1986 Mar; 73(1):39-44. PubMed ID: 3084714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catecholamines increase nerve growth factor mRNA content in both mouse astroglial cells and fibroblast cells.
    Furukawa Y; Tomioka N; Sato W; Satoyoshi E; Hayashi K; Furukawa S
    FEBS Lett; 1989 Apr; 247(2):463-7. PubMed ID: 2714445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
    Yamamoto M; Ujike H; Ogawa N
    Clin Neuropharmacol; 1985; 8(4):334-42. PubMed ID: 2416437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of catechol compound administration on nerve growth factor synthesis in the peripheral nervous system.
    Kaechi K
    Nihon Seikeigeka Gakkai Zasshi; 1992 Oct; 66(10):1051-8. PubMed ID: 1460376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.